FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/10/096376 [Registered on: 23/10/2025] Trial Registered Prospectively
Last Modified On: 22/10/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   The effect of intraoperative dexmedetomidine infusion administration on optic nerve sheath diameter in patients undergoing spinal surgery in prone position. 
Scientific Title of Study   Effect of intraoperative dexmedetomidine on optic nerve sheath diameter as a surrogate for intracranial pressure in patients undergoing spinal surgery in prone position: A randomized controlled study. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Purva 
Designation  Post Graduate 1st year 
Affiliation  Maulana Azad Medical College, New Delhi 
Address  Department of Anaesthesiology, Maulana Azad Medical College Campus, 2, Bahadur Shah Zafar Marg, near Delhi Gate, Balmiki Basti, New Delhi, Delhi

New Delhi
DELHI
110002
India 
Phone  9416220943  
Fax    
Email  purva2441987@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Bharti Wadhwa 
Designation  Director Professor 
Affiliation  Maulana Azad Medical College, New Delhi 
Address  Department of Anaesthesiology, Maulana Azad Medical College Campus, 2, Bahadur Shah Zafar Marg, near Delhi Gate, Balmiki Basti, New Delhi, Delhi

New Delhi
DELHI
110002
India 
Phone  9968604221  
Fax    
Email  drbhartitaneja@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Purva 
Designation  Post Graduate 1st year 
Affiliation  Maulana Azad Medical College, New Delhi 
Address  Department of Anaesthesiology, Maulana Azad Medical College Campus, 2, Bahadur Shah Zafar Marg, near Delhi Gate, Balmiki Basti, New Delhi, Delhi

New Delhi
DELHI
110002
India 
Phone  9416220943  
Fax    
Email  purva2441987@gmail.com  
 
Source of Monetary or Material Support  
Maulana Azad Medical College, New Delhi 
 
Primary Sponsor  
Name  Maulana Azad Medical College, New Delhi 
Address  Maulana Azad Medical College Campus, 2, Bahadur Shah Zafar Marg, near Delhi Gate, Balmiki Basti, New Delhi, Delhi, 110002 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Purva  Lok Nayak Hospital, New Delhi  Department of Anaesthesiology, Lok Nayak Hospital, Jawaharlal Nehru Marg, Maulana Azad Medical College Campus, Delhi Gate, New Delhi, Delhi, 110002
New Delhi
DELHI 
9416220943

purva2441987@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
MAULANA AZAD MEDICAL COLLEGE AND ASSOCIATED HOSPITAL ETHICS COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Dexmedetomidine group  Patients will be given dexmedetomidine infusion through IV line 0.5 mcg/kg/hour over 10 min after intubation followed by infusion of 0.4 mcg/Kg /hr continuously until skin closure and its effect on the intracranial pressure will be noted intraoperatively using optic nerve sheath diameter as a surrogate marker. 
Comparator Agent  Normal saline group  Patients will be started with normal saline infusion through the IV line at the same rate and this will act as a control group and the effect on intracranial pressure will be noted using optic nerve sheath diameter as a surrogate marker. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  Patients fulfilling American Society of Anesthesiologists (ASA) physical status I- II patients.
 
 
ExclusionCriteria 
Details  1. Patients with eye trauma or previous eye surgery.
2. Patients with glaucoma and ophthalmic disease other than refraction errors (myopia, hypermetropia).
3. Patient with cardiac conduction defects, significant cardiac disease and HR less than 60 per min.
4. Patients on beta blockers.
5. History of neurological disease and surgery.
6. History of increased intracranial pressure.
7. Severe Hepatic or renal disease
8. History of allergy to therapeutic drugs used in the study. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Double Blind Double Dummy 
Primary Outcome  
Outcome  TimePoints 
Mean difference in optic nerve sheath diameter 30 minutes after establishment of prone position.  T0 : Baseline (After induction) About 5 minutes after induction, when stabilization of cardiovascular status had been achieved, baseline optic nerve sheath diameter will be measured in the supine position.
T1: 30 minutes after establishment of prone positioning.
T2: One hour after T1
T3: At subsequent one-hour intervals
T4: After return to supine from prone position. 
 
Secondary Outcome  
Outcome  TimePoints 
Mean difference in optic nerve sheath diameter at induction, at one hourly interval after the first reading in prone position and
after return to supine from prone position. 
1. Baseline (After induction) About 5 min after induction, when stabilization of cardiovascular status had
been achieved, baseline optic nerve sheath diameter will be measured in the supine position.
2. One hour after the first reading in prone position.
3. At subsequent one-hour intervals
4. After return to supine from prone position. 
Association of duration of surgery on optic nerve sheath diameter in prone position.  After completion of the surgery and last optic nerve sheath diameter reading. 
Mean difference in airway pressures.  1. Baseline (After induction) About 5 min after induction, when stabilization of cardiovascular status had
been achieved.
2. 30 minutes after establishment of prone positioning.
3. One hour after the first reading in prone position.
4. At subsequent one-hour intervals
5. After return to supine from prone position. 
Mean difference in end tidal CO2 (EtCO2)   1. Baseline (After induction) About 5 min after induction, when stabilization of cardiovascular status had
been achieved.
2. 30 minutes after establishment of prone positioning.
3. One hour after the first reading in prone position.
4. At subsequent one-hour intervals
5. After return to supine from prone position. 
Mean difference in Mean Arterial Pressure (MAP).  1. Baseline (After induction) About 5 min after induction, when stabilization of cardiovascular status had
been achieved.
2. 30 minutes after establishment of prone positioning.
3. One hour after the first reading in prone position.
4. At subsequent one-hour intervals
5. After return to supine from prone position. 
 
Target Sample Size   Total Sample Size="20"
Sample Size from India="20" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 1 
Date of First Enrollment (India)   06/11/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Prone positioning increases the intracranial pressure that can be seen by using optic nerve sheath diameter as a surrogate marker. The study will be conducted in 2 groups. Group D will receive dexmedetomidine loading dose followed by maintenance dose during the induction. The other Group N will receive Normal saline infusion that will act as the control group. The induction of anaesthesia will be done as per the standard protocols. The hypothesis of this study is that dexmedetomidine reduces the intracranial pressure that is bound to increase in the prone spinal surgeries. This reduction in intracranial pressure will be measured by measuring the optic nerve sheath diameter. The optic nerve sheath diameter should not increase in the group D. 
Close